Planning for Safe Care: What Your Family Drug Court Needs to Know About Serving Pregnant Women With Opioid Use Disorders and Their Infants [Presentation Slides] (Presentation at the 2017 National Association of Drug Court Professionals Annual Training Conference, July 9-12, 2017, Oxen Hill, MD).
Young, Nancy K.
National Association of Drug Court Professionals Annual Training Conference (2017 : Oxen Hill, MD).
National Center on Substance Abuse and Child Welfare.
Presentation Training Material Conference Materials
Children and Family Futures
4940 Irvine Boulevard, Suite 202
Irvine, CA 92620
Intended for professionals working in family drug courts, this federally funded slide presentation explains best practices in the treatment of opioid use disorders for parenting and pregnant women and for infants prenatally exposed to opioids, and how the Child Abuse and Prevention Treatment Act (CAPTA) provisions on prenatal substance exposure can improve outcomes for families. Section 1 reviews the scope of the drug problem and the increase in overdose deaths from 2000-2014. Data is shared on the number of children in out of home care from 2000 to 2015 that shows a decrease until 2012 and a rise in numbers to 2015, and an increase in parental alcohol or other drug use (AOD) as a contributing factor for reason for removal from 18.5% in 2000 to 34.4% in 2015. Additional charts show the prevalence of parental AOD as contributing factor for removal by State, the age of children removed with parental AOD as a reason for removal, the estimated number of infants affected by prenatal exposure by type of substance and infant disorder, and the increase in the rate of neonatal abstinence syndrome (NAS) from 2000-2013. Information is then provided on NAS treatment, primary changes in CAPTA that address substance-exposed infants and implications for State policy, and Plan of Safe Care principles and components. The following section focuses on the transformation of Family Drug Courts and provides information on medication assisted treatment (MAT) in drug courts, nine components of successful MAT programs in drug court settings, strategies for supporting pregnant women with opioid use disorders, barriers to screening, assessment during pregnancy, and treatment for opioid use disorders in pregnancy and the postpartum period. A chart showing the continuum of family-based services is provided, and strategies for implementing a family-focused approach are listed.
CHILD WELFARE SERVICES; DRUG THERAPY; SUBSTANCE EXPOSED INFANTS; ADDICTED INFANTS; PRENATAL CHILD ABUSE; PRENATAL DRUG EXPOSURE; SUBSTANCE ABUSING MOTHERS; FAMILY DRUG COURTS; FAMILY CENTERED SERVICES